---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-024344"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2026-03-06T23:59:59+00:00"
generated_at: "2026-05-15T18:50:21.271241+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BiomX CEO and Chairman resign; Michael Oster appointed new CEO, Amir Shalom joins board

## Summary
- Jonathan Solomon resigned as CEO and director effective March 4, 2026; no disagreement with company.
- Dr. Russell Greig resigned as Chairman and director effective same date; no disagreement cited.
- Board appointed Michael Oster as CEO; previously CEO of Saffron Tech Ltd. and Sattivus Tech Corp.
- Board appointed Amir Shalom as Class I director; operations manager at Barzilai Medical Center.
- New committee assignments: Liat Bidas chairs Audit; Amir Shalom chairs Compensation; Liat Bidas chairs Nominating and Governance.

## SEC filing metadata
- accession: 0001213900-26-024344
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2026-03-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390026024344/0001213900-26-024344-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390026024344/ea0280337-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-024344
- JSON: https://secwatch.observer/filing/0001213900-26-024344.json
- Plain text: https://secwatch.observer/filing/0001213900-26-024344.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.